Catheter News and Research RSS Feed - Catheter News and Research

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.
Clot-busting medications for treating pulmonary embolism patients linked with fewer deaths

Clot-busting medications for treating pulmonary embolism patients linked with fewer deaths

Bringing clarity to a decades-long debate, a national team of researchers led by experts from the Perelman School of Medicine at the University of Pennsylvania has found that adding clot-busting medications known as thrombolytics to conventional approaches when treating sudden-onset pulmonary embolism patients is associated with 47 percent fewer deaths than using standard intravenous or under-the-skin anticoagulant medications alone. [More]
Doctors weigh how to use new heart-valve procedure

Doctors weigh how to use new heart-valve procedure

The procedure is less invasive than surgery but is still unproven for many patients, The Wall Street Journal reports. Meanwhile, the Journal also looks at how some doctors are using Google Glass to have more time with their patients. [More]
First Edition: June 17, 2014

First Edition: June 17, 2014

Today's headlines include developments related to the health care marketplace and state health policy. [More]
Covidien receives FDA approval for Apollo Onyx delivery micro catheter

Covidien receives FDA approval for Apollo Onyx delivery micro catheter

Covidien plc today announced U.S. Food and Drug Administration approval of its Apollo Onyx delivery micro catheter - the first detachable tip micro catheter available in the U.S. [More]
Ohio State doctors treat heart failure patients with new wireless, implantable hemodynamic monitor

Ohio State doctors treat heart failure patients with new wireless, implantable hemodynamic monitor

Doctors at The Ohio State University Wexner Medical Center are the first in the country to begin treating some heart failure patients with a new wireless, implantable hemodynamic monitor that was just approved by the U.S. Food and Drug Administration. The monitor will help physicians observe pulmonary artery pressures, optimize treatment and prevent hospitalizations. [More]
Disinfection caps, 'scrub-the-hub' regimens reduce bloodstream infections, cut costs

Disinfection caps, 'scrub-the-hub' regimens reduce bloodstream infections, cut costs

Whether through the use of alcohol-containing caps or basic cleaning of the injection port of the central line, infection preventionists at three hospitals are finding successful ways to stop germs from entering central line catheters and causing bloodstream infections in patients. [More]
Concise analysis of robotics and surgical navigation systems in the U.S. market

Concise analysis of robotics and surgical navigation systems in the U.S. market

Reportlinker.com announces that a new market research report is available in its catalogue: U.S. Market for Surgical Navigation Systems and Robotics [More]
Longer looks: When an ER doctor becomes an ER patient; visualizing end-of-life treatments; Google Glass inside operating rooms

Longer looks: When an ER doctor becomes an ER patient; visualizing end-of-life treatments; Google Glass inside operating rooms

If you are shot or stabbed in or around Oakland, you are likely to be sent [to Highland Hospital). Oakland has the highest violent crime rate in the nation, so I have indeed seen my fair share of victims over my long career here. [More]
Edge Therapeutics commences enrollment in second cohort of EG-1962 Phase 1/2 NEWTON study for aSAH

Edge Therapeutics commences enrollment in second cohort of EG-1962 Phase 1/2 NEWTON study for aSAH

Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies for acute, life-threatening neurological conditions, today announced that it has initiated patient enrollment in the second cohort of the NEWTON study, a multicenter, randomized, controlled, open-label, Phase 1/2 clinical trial of the company's lead product candidate, EG-1962. [More]
Disinfection caps reduce CLABSI events by 68%

Disinfection caps reduce CLABSI events by 68%

Thanks to the simple use of an alcohol-impregnated cap, Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period. [More]
Loyola achieves 68% decrease in central line-associated bloodstream infections

Loyola achieves 68% decrease in central line-associated bloodstream infections

Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period. A two-year study compared the use of disinfection caps to an intense scrub-the-hub intervention to standard care. Scrub-the-hub refers to cleaning catheter connector hubs and injection ports with alcohol for the recommended 15 seconds before accessing the central line, a catheter placed in a large vein to deliver medicine and liquids during hospitalization. [More]
STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced the signing of the acquisition agreement of Cappella Peel Away Inc. (Delaware, USA) and its assets relating to a novel stent delivery system. The acquisition is subject to closing conditions. [More]
Unsterile living conditions, untrained caregivers contribute to infections in home health settings

Unsterile living conditions, untrained caregivers contribute to infections in home health settings

Millions of Americans depend on home health care services to recover from surgeries and hospital stays, as well as to manage daily life with chronic conditions. [More]
Nerve block technique offers potentially speedier recovery for orthopedic surgery patients

Nerve block technique offers potentially speedier recovery for orthopedic surgery patients

A Virginia Mason study has determined that a nerve block technique which avoids the femoral nerve results in the need for less morphine and a potentially speedier recovery for orthopedic surgery patients. [More]
St. Jude Medical's EnligHTN renal denervation system safe, effective for treating drug-resistant hypertension

St. Jude Medical's EnligHTN renal denervation system safe, effective for treating drug-resistant hypertension

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced preliminary results from the EnligHTN III study, which found the company's second-generation EnligHTN™ renal denervation system provided safe and effective therapy for patients with drug-resistant, uncontrolled hypertension six months post-procedure. The results were presented during a hot line late-breaking clinical trial session at EuroPCR 2014. [More]
Serious complications due to anesthesia during childbirth are very rare

Serious complications due to anesthesia during childbirth are very rare

Expectant mothers concerned about receiving an epidural, spinal or general anesthesia during childbirth can breathe a little easier. According to a study published in the June issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, serious complications due to anesthesia during childbirth are very rare, occurring in one out of every 3,000 deliveries. [More]

Use of simulation techniques in medical education results in improved patient care, better outcomes

The use of simulation techniques in medical education, such as lifelike mannequins and computer systems, results in improved patient care, better outcomes and other benefits, according to a study led by a Loyola University Chicago Stritch School of Medicine researcher. [More]

Amsel Medical files 510(K) Pre-Marketing Notification with FDA for Amsel Occluder Device

Amsel Medical Corporation today announced that it has successfully completed filing of a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration (FDA) for its Amsel Occluder Device. [More]
Juventas presents positive trial results of JVS-100 drug delivered by Biocardia’s Helix transendocardial system

Juventas presents positive trial results of JVS-100 drug delivered by Biocardia’s Helix transendocardial system

BioCardia®, Inc., a leader in cardiovascular regenerative medicine, today announced the presentation by Juventas Therapeutics of their positive four-month results for their STOP-HF Trial. [More]
New technique can predict which stroke victims will benefit from clot-busting drugs

New technique can predict which stroke victims will benefit from clot-busting drugs

Johns Hopkins researchers say they have developed a technique that can predict — with 95 percent accuracy — which stroke victims will benefit from intravenous, clot-busting drugs and which will suffer dangerous and potentially lethal bleeding in the brain. [More]